Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 4 3Phase 3 3Phase 2 3Phase 1 3Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Head & Neck 1

Conditions

Paclitaxel-induced Neuropathy 1Mesothelioma 1Head and Neck Neoplasms 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × Magnesium Sulfate × Clear all
NCT04481672 2022-01-11

Intravenous Magnesium in Patients Receiving Cisplatin

Dana-Farber Cancer Institute

Phase 1 Completed
5 enrolled
Other solid neoplasmThoracic

Mesothelioma

NCT01804205 2018-03-14

Magnesium Sulphate and Rocuronium in Patients Over 60

Instituto Nacional de Cancer, Brazil

Phase 1 Completed
64 enrolled
Head & Neck

Head and Neck Neoplasms

NCT01682499 2014-09-25

Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy

Beth Israel Medical Center

Phase 1 Completed
50 enrolled

Paclitaxel-induced Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡